Furthermore, studies from animal models and clinical trials have shown that progesterone via its receptor PR is a major player in development and growth of breast cancer and uterine fibroids, however, PR inhibits the development of estrogen-driven endometrial cancer (Ishikawa et al., 2010; Kim, Kurita & Bulun, 2013). The gene discussed is PGR; the disease is endometrial cancer.